Currently holds a position at Outlook Therapeutics Inc
Position | Company | Period |
---|---|---|
Chief Operating Officer | Outlook Therapeutics Inc | Nov. 30, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-04-21 | 2023-04-20 |
Outlook Therapeutics Inc
(OTLK)
|
S Sale |
520,000
-44.3%
1.14590,200 USD |
520,000 -44.3% | 1.14 | 590,200 USD | |
2022-06-23 | 2022-06-21 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
10,000
+0.9%
1.0510,500 USD |
10,000 +0.9% | 1.05 | 10,500 USD | |
2021-12-06 | 2021-12-06 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
25,201
+2.2%
1.3834,777 USD |
25,201 +2.2% | 1.38 | 34,777 USD | |
2021-12-03 | 2021-12-03 |
Outlook Therapeutics Inc
(OTLK)
|
B Purchase |
10,000
+0.9%
1.4214,200 USD |
10,000 +0.9% | 1.42 | 14,200 USD | |
2021-02-25 | 2021-02-23 |
Outlook Therapeutics Inc
(OTLK)
|
S Sale |
15,900
-1.4%
2.0933,199 USD |
15,900 -1.4% | 2.09 | 33,199 USD | |
2021-02-17 | 2021-02-12 |
Outlook Therapeutics Inc
(OTLK)
|
S Sale |
63,700
-5.3%
2.55162,435 USD |
63,700 -5.3% | 2.55 | 162,435 USD |